Differentiating celiac disease from other diseases: Difference between revisions

Jump to navigation Jump to search
Mmir (talk | contribs)
Mmir (talk | contribs)
Line 111: Line 111:
| +/-
| +/-
|
|
* enhanced [[gastrointestinal]] motility and [[gastrointestinal]] sound
* Enhanced [[gastrointestinal]] motility and [[gastrointestinal]] sound
* Mild [[abdominal tenderness]]
* Mild [[abdominal tenderness]]
* [[Abdominal distension|Abdominal bloating]]
* [[Abdominal distension|Abdominal bloating]]
Line 232: Line 232:
** [[Pharmacological|Pharmacologic]] studies based criteria
** [[Pharmacological|Pharmacologic]] studies based criteria
|-
|-
! align="center" style="background:#DCDCDC;" |[[lactose intolerance]]
! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]]
| -
| -
| +
| +
Line 254: Line 254:
* Reduction of lactase enzyme activity or lactase nonpersistence
* Reduction of lactase enzyme activity or lactase nonpersistence
* Congenital lactase deficiency
* Congenital lactase deficiency
|lactase activity assay
|Lactase activity assay
|-
|-
! align="center" style="background:#DCDCDC;" |[[Whipple's disease|Whipple disease]]
! align="center" style="background:#DCDCDC;" |[[Whipple's disease|Whipple disease]]
Line 293: Line 293:
* Profuse, repetitive [[vomiting]]
* Profuse, repetitive [[vomiting]]
|[[Autoimmunity|Autoimmune]]/[[Allergy|allergic]] response to food [[antigens]]
|[[Autoimmunity|Autoimmune]]/[[Allergy|allergic]] response to food [[antigens]]
|[[oral]] food challenge (OFC)
|[[Oral]] food challenge (OFC)
|-
|-
! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] 
! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] 
Line 313: Line 313:
* Associated with an identifiable [[dietary]] [[antigen]]
* Associated with an identifiable [[dietary]] [[antigen]]
|[[Autoimmunity|Autoimmune]]/[[Allergy|allergic]] response to food [[antigens]]
|[[Autoimmunity|Autoimmune]]/[[Allergy|allergic]] response to food [[antigens]]
|[[eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]]
|[[Eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]]
! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]]
Line 333: Line 333:
* Fecal urgency
* Fecal urgency
* [[Incontinence]]
* [[Incontinence]]
* My be associated with extraintestinal symptoms, such as:
* May be associated with extraintestinal symptoms, such as:
** [[Arthralgia]]
** [[Arthralgia]]
** [[Arthritis]]
** [[Arthritis]]
Line 395: Line 395:
* Acidic
* Acidic
|
|
* severe life-threatening [[diarrhea]]
* Severe life-threatening [[diarrhea]]
* [[Dehydration]]
* [[Dehydration]]
* Symptomatic as long as the diet includes [[lactose]] or its [[hydrolysis]] products, [[glucose]] and [[galactose]]
* Symptomatic as long as the diet includes [[lactose]] or its [[hydrolysis]] products, [[glucose]] and [[galactose]]
Line 422: Line 422:
|
|
* [[Clumsiness]]
* [[Clumsiness]]
* vision impairment
* Vision impairment
* [[Ataxia]]
* [[Ataxia]]
|
|
* [[autosomal recessive]] disorder caused by mutations encoding the [[microsomal]] [[triglyceride]] transfer protein (MTP)
* [[Autosomal recessive]] disorder caused by mutations encoding the [[microsomal]] [[triglyceride]] transfer protein (MTP)
|
|
* Clinical findings and low [[triglyceride]] and [[cholesterol]] level
* Clinical findings and low [[triglyceride]] and [[cholesterol]] level
Line 443: Line 443:
* Disease hetergenicity lead to varying presentation from chronic [[diarrhea]] without significant fat [[Malabsorption|malabsorptio]]<nowiki/>n to severe [[watery diarrhea]] and steatorrhea with [[malnutrition]]
* Disease hetergenicity lead to varying presentation from chronic [[diarrhea]] without significant fat [[Malabsorption|malabsorptio]]<nowiki/>n to severe [[watery diarrhea]] and steatorrhea with [[malnutrition]]
|
|
* [[genetic defects]] in ''SLC10A2'' (solute carrier family 10 member 2 gene)
* [[Genetic defects]] in ''SLC10A2'' (solute carrier family 10 member 2 gene)
|
|
* Total and specific [[bile acid]]<nowiki/>s from stool
* Total and specific [[bile acid]]<nowiki/>s from stool
Line 461: Line 461:
* Elevated serum [[chromogranin A]]
* Elevated serum [[chromogranin A]]
|
|
* [[heartburn]]
* [[Heartburn]]
|
|
* [[Gastrin]] producing tumor mainly in [[duodenum]]
* [[Gastrin]] producing tumor mainly in [[duodenum]]

Revision as of 11:37, 13 September 2017

Celiac disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Celiac disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Life Style Modifications
Pharmacotherapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Differentiating celiac disease from other diseases On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Differentiating celiac disease from other diseases

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Differentiating celiac disease from other diseases

CDC on Differentiating celiac disease from other diseases

Differentiating celiac disease from other diseases in the news

Blogs onDifferentiating celiac disease from other diseases

Directions to Hospitals Treating Celiac disease

Risk calculators and risk factors for Differentiating celiac disease from other diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Differentiating Celiac Disease from Other Diseases

Celiac disease must be differentiated from other diseases presenting as chronic diarrhea. The table below summarizes the findings that differentiate causes of chronic diarrhea[1][2][3][4][5][6][7]

Cause Diarrhea Peak age of onset History Physical exam Lab findings Additional finding Cause/Pathogenesis Gold standard dignosis
Watery Fatty Weight loss FTT Abdominal pain
Celiac disease +/- +/- Childhood

Adult

+ + +
Lactose intolerance + - Adult - - +
  • Stool osmotic gap of >125 mOsm/kg 
  • Stool pH <6 
Cystic fibrosis - + Infancy and childhood + + +
  • Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein
Laxative overuse + - After childhood +/- - +/- -
Crohns disease + - Young adults

(20th)

+ +
  • Abnormal immune response to self antigens
Hyperthyroidism + - Any age + - +/-
  • Elevated T4
  • Elevated T3
  • Decreased level of TSH
VIPoma + - Between 30 and 50 + +/- +/-
  • Primary secretory tumor
  • Elevated VIP levels
  • Followed by imaging
Irritable bowel syndrome + - Between 30 and 50 - - + -
  • Postinfectious
  • Inflammatory
Lactose intolerance - + Any age + - +/-
  • Reduction of lactase enzyme activity or lactase nonpersistence
  • Congenital lactase deficiency
Lactase activity assay
Whipple disease +/- + 50th + - + Tropheryma whipplei  Upper endoscopy with biopsies of the small intestine for T. whipplei testing (histology with PAS staining, polymerase chain reaction [[[PCR]]] testing, and immunohistochemistry)
Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) + - Infancy +/- +/- + Stool examination:
  • Triggered by cow's milk protein
  • Profuse, repetitive vomiting
Autoimmune/allergic response to food antigens Oral food challenge (OFC)
Eosinophilic gastroenteritis  + - 30th +/- +/- + Autoimmune/allergic response to food antigens Eosinophilic infiltration of the gastrointestinal tract on biopsy
Microscopic colitis + - 60th + - +
Congenital chloride diarrhea + - Neonate + + - -

Mutations in the SLC26A3 gene

Congenital sodium diarrhea + - Neonate + + - - Stool examination:

Serum:

  • Mutations in the SPINT2 gene
Clinical
Glucose-galactose malabsorption + - Infancy + +/- + Abdominal tenderness Stool examination:
  • Acidic
  • Mutations in solute carrier family 5, member 1 gene (SLC5A1, also known as SGLT1)
    • Lead to deficiency in the intestinal sodium/glucose transporter
Abetalipoproteinemia - + Infancy + + +
Primary bile acid malabsorption + +/- Childhood Adolescents + + +/- -
Gastrinoma (Zollinger-Ellison syndrome) + - Between the ages of 20 and 50 + +/- +
  • Elevated basal or stimulated serum gastrin more than 1000 pg/mL

References

  1. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology". Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.
  2. Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D (2002). "Bowel habits and bile acid malabsorption in the months after cholecystectomy". Am J Gastroenterol. 97 (7): 1732–5. doi:10.1111/j.1572-0241.2002.05779.x. PMID 12135027.
  3. Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R; et al. (1991). "Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia". Gastroenterology. 100 (2): 359–69. PMID 1702075.
  4. RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC (1960). "Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue". Gastroenterology. 38: 28–49. PMID 14439871.
  5. Hertzler SR, Savaiano DA (1996). "Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance". Am J Clin Nutr. 64 (2): 232–6. PMID 8694025.
  6. Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC (1997). "Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?". Gut. 41 (5): 632–5. PMC 1891556. PMID 9414969.
  7. BLACK-SCHAFFER B (1949). "The tinctoral demonstration of a glycoprotein in Whipple's disease". Proc Soc Exp Biol Med. 72 (1): 225–7. PMID 15391722.

Template:WH Template:WS